WEBINAR REPLAY: "Chest Tube Management in Cardiac Surgery" | ERAS Cardiac Society Webinar in collaboration with CTSNet

Key speakers Marc Gillinov, MD, Jurij M. Kalisnik, MD, and Lenard Conradi, MD discuss the clinical implications of retained blood, current strategies in chest tube management, and the benefits of posterior pericardiotomy.
Webinar moderated by Kevin Lobdell, MD, and Marc Gerdisch, MD.



Clear Catheter Systems Wins Prestigious International Innovation Award


2013 “Innovations in Cardiovascular Interventions” Top Prize goes to Medical Device Start-up for PleuraFlow

Clear Catheter Systems, Inc., announced today it has won the 2013 Innovations in Cardiovascular Interventions (ICI) Best Start-Up Innovation Award for its medical device, PleuraFlow®, a novel system that optimally evacuates blood and fluid after surgery to speed recovery and improve patient outcomes in the ICU during the initial critical hours after heart surgery. PleuraFlow12_13

The honor was awarded to Dr. Edward Boyle, a surgeon, Chairman of Clear Catheter Systems and an inventor of the PleuraFlow® device, which prevents chest tube clogging to minimize the problem of Retained Blood Complications after heart surgery. Clear Catheter Systems plans to expand use of its PleuraFlow® Active Clearance Technology® by hospitals and clinicians to improve recovery, implementing an easy to use bedside system that keeps evacuation devices optimally functioning in the post heart and thoracic surgery recovery period.

“For optimal outcome all patients require evacuation of blood and fluid from around their hearts and lungs while recovering from heart surgery,” said Boyle. “Blood evacuation can be incomplete in nearly one out of five patients, contributing to significant complications and costs.”

The ICI brings together thousands of participants from around the world, representing the healthcare industry, governments, hospitals, venture capital funds, prominent scientists and key opinion leaders in the cardiovascular field. The ICI Innovation Award is the world’s most prestigious award for cardiovascular start-ups.  Finalists were selected in a rigorous peer reviewed process by a panel of judges.

“We are honored to be recognized by such an important forum of leading cardiovascular experts. Retained Blood Complications impact outcomes and cost hospitals millions of dollars annually. The judges clearly recognized the need for better technology to improve patient care post operatively. We are proud of the work we do and of the ICI Innovation Award,” said Paul Molloy, Chief Executive Officer of Clear Catheter Systems.

2013 ISI Presentation web


ICI Winners web2


2013 ICI Boyle Presentation